Related Experiment Video
Updated: Sep 23, 2025

08:30
Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
12.5K
Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice
Christina Bruss1, Kerstin Kellner1, Olaf Ortmann1
1Department of Gynecology and Obstetrics, University Medical Center Regensburg, 93053 Regensburg, Germany.
Cancers
|May 14, 2022
Summary
Standardized immune cell profiling in humanized patient-derived xenograft (hPDX) models reveals distinct T and B cell populations. This approach aids in understanding immune cell patterns in cancer progression and checkpoint-related complications.
Area of Science:
- Immunology
- Oncology
- Preclinical Models
Background:
- Humanized mice are crucial preclinical models for cancer research.
- Standardizing immune cell phenotyping is vital for analyzing immune responses in cancer.
- Humanized patient-derived xenograft (hPDX) models combine human immune systems with patient tumors.
Purpose of the Study:
- To apply established immune cell profiling protocols to hPDX models.
- To characterize immune cell patterns in hPDX models.
- To assess the impact of CD34+ stem cell transplantation on immune reconstitution.
Main Methods:
- Utilized established protocols for multicolor immune cell profiling via flow cytometry.
- Transplanted CD34+ stem cells into mice to create hPDX models.
- Analyzed T and B cell differentiation, regulatory T cells (Tregs), and exhausted T cells.
Main Results:
- Immune reconstitution levels were independent of transplanted CD34+ cell quantity.
- Low-level CD3+ cell contamination in HSC transplants did not impair T cell maturation.
- Identified diverse B and T cell differentiation stages, including Tregs and exhausted T cells expressing TIGIT, PD-1, or KLRG1.
Conclusions:
- Standardized flow cytometry protocols are effective for immune cell characterization in hPDX models.
- This methodology enhances the understanding of immune-oncologic processes.
- hPDX models with standardized profiling offer valuable insights into human cancer progression.

